Targeting CDC25C, PLK1 and CHEK1 to overcome Docetaxel resistance induced by loss of LZTS1 in prostate cancer
Nader Al Nakouzi(University of British Columbia), Anne Chauchereau(Inserm)
Cited by 43
Related Papers
Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis
|EMBO Molecular Medicine|2016|31